(Q45357722)

English

Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers

scientific article published on 14 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

ChEBI release 2020-05-28

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Ellen Hulskotte

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Samir Gupta

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Fengjuan Xuan

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Marga van Zutven

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Edward O'Mara

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Hwa-Ping Feng

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

John Wagner

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Joan Butterton

8

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

14 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1622-1630

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Boceprevir for previously treated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

Boceprevir for untreated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

Treatment of hepatitis C after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

Quantitative liver function tests in donors and recipients of living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

21 January 2018

Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25831

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.25831

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45357722&oldid=2143302606"